SP1 and gastric cancer: When combining TRIM25 and SP1 or MMP2 together as a new variable, patients with GC were divided into three subgroups: high level of TRIM25 and low level of SP1 or MMP2; low level of TRIM25 and high level of SP1 or MMP2; and both low/high.